Skip to content

Capecitabine EP Impurity C

Capecitabine EP Impurity C

Product Description
CAT No.
ALN-C003004
CAS No.
161599-46-8
Mol. F.
C13H16FN3O6
Mol. Wt.
329.3
Stock
Please Inquire
RFQ
Chemical Name : 1-(2,3-di-O-acetyl-5-deoxy-β-D-ribofuranosyl)-4-amino-5-fluoropyrimidin-2(1H)-one (as per EP) 2′,3′-Di-O-acetyl-5′-deoxy-5-fluorocytidine (as per USP)
Smiles : C[C@@H]1[C@H]([C@H]([C@H](N2C(N=C(C(F)=C2)N)=O)O1)OC(C)=O)OC(C)=O
Inchi : InChI=1S/C9H11FN2O5/c1-3-5(13)6(14)8(17-3)12-2-4(10)7(15)11-9(12)16/h2-3,5-6,8,13-14H,1H3,(H,11,15,16)/t3?,5?,6?,8-/m1/s1
Synonym : Capecitabine Diacetyl Amino Impurity

Design of experiments (DoE) - based enhanced quality by design approach to hydrolytic degradation kinetic study of capecitabine by eco-friendly stability indicating UV-visible spectrophotometry

By Prajapati, Pintu; Patel, Radhika; Patel, Dilan; Shah, ShaileshnFrom American Journal of PharmTech Research (2020), 10(6), 115-133

Validated stability indicating HPLC method for estimation of capecitabine

By Lalitha, K. V.; Raveendra Reddy, J.; Devanna, N. – From International Journal of Pharmaceutical Sciences and Research (2020), 11(11), 5651-5658

RP-HPLC method development and validation for the simultaneous estimation of Irinotecan hydrochloride and Capecitabine in Active Pharmaceutical Ingredients (APIs)

By Vijaya Jyothi, M.; Bhargav, E.; Keerthana, B.; Varalakshmi, Devi K. – From International Journal of Research in Pharmaceutical Sciences (Madurai, India) (2018), 9(1), 63-67

Request For Quotation

Related Products